NCT00619931View on ClinicalTrials.gov

A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Healthy
Interventions
DRUG

APD791

APD791 or matching placebo in escalating doses

Trial Locations (1)

68502

MDS Pharma Services, Lincoln

Sponsors
All Listed Sponsors
lead

Arena Pharmaceuticals

INDUSTRY

NCT00619931 - A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers | Biotech Hunter | Biotech Hunter